Valeant Said to Be Near to Acquiring Bausch & Lomb

Valeant Pharmaceuticals International Inc., Canada’s largest drugmaker, is close to acquiring Bausch & Lomb Holdings Inc., the eye-care company owned by Warburg Pincus LLC, for about $9 billion, said a person with knowledge of the negotiations.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.